-
Loading metrics
Open Access
Peer-reviewed
Research Article
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
-
Runxia Gu ,
Contributed equally to this work with: Runxia Gu, Hui Wei
Roles Data curation, Formal analysis, Software, Visualization, Writing – original draft
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Hui Wei ,
Contributed equally to this work with: Runxia Gu, Hui Wei
Roles Conceptualization, Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Ying Wang,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Dong Lin,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Bingcheng Liu,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Chunlin Zhou,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Kaiqi Liu,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Benfa Gong,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Shuning Wei,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Guangji Zhang,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Xiaoyuan Gong,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Yuntao Liu,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Yan Li,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Xingli Zhao,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Shaowei Qiu,
Roles Resources
Affiliation Department of Leukemia, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Huijun Wang,
Roles Methodology
Affiliation Department of Pathology and Lab Medicine, Institute of Hematology, Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Tianjin, China
⨯ -
Min Wang,
Roles Methodology
Affiliation State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⨯ -
Yingchang Mi,
Roles Supervision, Validation
Affiliation State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⨯ - [ ... ],
-
Jianxiang Wang
Roles Conceptualization, Funding acquisition, Project administration, Writing – review & editing
* E-mail: wangjx@ihcams.ac.cn
Affiliation State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⨯ - [ view all ]
- [ view less ]
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
- Runxia Gu,
- Hui Wei,
- Ying Wang,
- Dong Lin,
- Bingcheng Liu,
- Chunlin Zhou,
- Kaiqi Liu,
- Benfa Gong,
- Shuning Wei,
- Guangji Zhang
- Published: July 5, 2017
- https://doi.org/10.1371/journal.pone.0180624